Corvus Pharmaceuticals, Inc. (CRVS)
Corvus Pharmaceuticals, Inc. (CRVS) Insider Trading
Directors, officers and holders of more than 10% of CRVS report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 59 transactions on file: 3 with code P, 2 with code S and 45 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 11, 2026 | van den Broek Richard | Director | A Award | 15,000 | Not measured | Not measured |
| Jun 11, 2026 | Thompson Peter A. | Director | A Award | 15,000 | Not measured | Not measured |
| Jun 11, 2026 | Grais Linda | Director | A Award | 15,000 | Not measured | Not measured |
| Jun 11, 2026 | CLARK IAN T | Director | A Award | 15,000 | Not measured | Not measured |
| Jun 11, 2026 | Moore David Scott | Director | A Award | 15,000 | Not measured | Not measured |
| Jun 11, 2026 | Moore David Scott | Director | P Purchase | 21,700 | $11.53 | $250,236 |
| May 18, 2026 | MILLER RICHARD A MD | President and CEO | P Purchase | 5,000 | $12.05 | $60,250 |
| May 18, 2026 | MILLER RICHARD A MD | President and CEO | P Purchase | 1,932 | $12.01 | $23,203 |
| Apr 23, 2026 | Chan Andrew C. | Director | A Award | 30,000 | Not measured | Not measured |
| Jan 28, 2026 | Thompson Peter A. | Director | M Exercise | 15,000 | $0.9899 | $14,849 |
| Jan 28, 2026 | Thompson Peter A. | Director | M Exercise | 15,000 | $2.49 | $37,350 |
| Jan 28, 2026 | Thompson Peter A. | Director | M Exercise | 15,000 | $1.64 | $24,600 |
| Jan 28, 2026 | Thompson Peter A. | Director | M Exercise | 15,000 | $2.12 | $31,800 |
| Jan 28, 2026 | Thompson Peter A. | Director | M Exercise | 15,000 | $0.9650 | $14,475 |
| Jan 28, 2026 | Thompson Peter A. | Director | M Exercise | 30,000 | $15.00 | $450,000 |
| Jan 28, 2026 | Thompson Peter A. | Director | M Exercise | 15,000 | $9.70 | $145,500 |
| Jan 28, 2026 | Thompson Peter A. | Director | M Exercise | 15,000 | $12.50 | $187,500 |
| Jan 28, 2026 | Thompson Peter A. | Director | M Exercise | 15,000 | $3.61 | $54,150 |
| Jan 28, 2026 | Thompson Peter A. | Director | M Exercise | 15,000 | $2.00 | $30,000 |
| Jan 28, 2026 | Thompson Peter A. | Director | M Exercise | 15,000 | $3.27 | $49,050 |
| Jan 28, 2026 | Thompson Peter A. | Director | M Exercise | 15,000 | $2.74 | $41,100 |
| Jan 28, 2026 | Thompson Peter A. | Director | M Exercise | 15,000 | $2.60 | $39,000 |
| Jan 28, 2026 | Thompson Peter A. | Director | M Exercise | 30,000 | Not measured | Not measured |
| Jan 28, 2026 | Thompson Peter A. | Director | M Exercise | 15,000 | Not measured | Not measured |
| Jan 28, 2026 | Thompson Peter A. | Director | M Exercise | 15,000 | Not measured | Not measured |
| Jan 28, 2026 | Thompson Peter A. | Director | M Exercise | 15,000 | Not measured | Not measured |
| Jan 28, 2026 | Thompson Peter A. | Director | M Exercise | 15,000 | Not measured | Not measured |
| Jan 28, 2026 | Thompson Peter A. | Director | M Exercise | 15,000 | Not measured | Not measured |
| Jan 28, 2026 | Thompson Peter A. | Director | M Exercise | 15,000 | Not measured | Not measured |
| Jan 28, 2026 | Thompson Peter A. | Director | M Exercise | 15,000 | Not measured | Not measured |
| Jan 28, 2026 | Thompson Peter A. | Director | M Exercise | 15,000 | Not measured | Not measured |
| Jan 28, 2026 | Thompson Peter A. | Director | M Exercise | 15,000 | Not measured | Not measured |
| Jan 28, 2026 | Thompson Peter A. | Director | M Exercise | 15,000 | Not measured | Not measured |
| Jan 28, 2026 | Thompson Peter A. | Director | M Exercise | 15,000 | Not measured | Not measured |
| Jan 28, 2026 | Thompson Peter A. | Director | M Exercise | 15,000 | Not measured | Not measured |
| Dec 4, 2025 | MILLER RICHARD A MD | President and CEO | A Award | 1,000,000 | Not measured | Not measured |
| Dec 4, 2025 | Jones William Benton | See Remarks | A Award | 400,000 | Not measured | Not measured |
| Dec 4, 2025 | LEA LEIV | Chief Financial Officer | A Award | 400,000 | Not measured | Not measured |
| Dec 4, 2025 | Arcara Jeffrey | Chief Business Officer | A Award | 100,000 | Not measured | Not measured |
| Oct 2, 2025 | Moore David Scott | Director | A Award | 30,000 | Not measured | Not measured |
| Jun 27, 2025 | Thompson Peter A. | Director | X In-the-Money | 1,397,684 | $3.50 | $4,891,894 |
| Jun 27, 2025 | ORBIMED ADVISORS LLC | Director | X In-the-Money | 1,397,684 | $3.50 | $4,891,894 |
| Jun 27, 2025 | ORBIMED ADVISORS LLC | Director | X In-the-Money | 1,397,684 | Not measured | Not measured |
| Jun 27, 2025 | Thompson Peter A. | Director | X In-the-Money | 1,397,684 | Not measured | Not measured |
| Jun 27, 2025 | Thompson Peter A. | Director | S Sale | 1,176,332 | $4.16 | $4,891,894 |
| Jun 27, 2025 | ORBIMED ADVISORS LLC | Director | S Sale | 1,176,332 | $4.16 | $4,891,894 |
| Jun 12, 2025 | Thompson Peter A. | Director | A Award | 15,000 | Not measured | Not measured |
| Jun 12, 2025 | CLARK IAN T | Director | A Award | 15,000 | Not measured | Not measured |
| Jun 12, 2025 | Grais Linda | Director | A Award | 15,000 | Not measured | Not measured |
| Jun 12, 2025 | Morrison Scott W | Director | A Award | 15,000 | Not measured | Not measured |
The full Form 4 history is on the CRVS company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.